The effective utilization of NGS testing in clinical diagnostics requires flexible and comprehensive software solutions that can reliably support multiple testing indications. Velsera’s assay and sequencer agnostic CGW Plus platform is an adaptive, workflow-optimized tertiary analysis and reporting solution designed to consolidate case review across solid tumor, hematologic malignancy, and now germline testing indications. In this session, we will introduce the expanded capabilities of CGW Plus, highlighting how its intuitive and purpose-built design now supports streamlined case review across multiple testing indications. With robust secondary analysis powered by the industry-leading Velsera Seven Bridges platform, CGW Plus provides a seamless and scalable solution to support laboratories. Gain insight into the platform’s evolving feature set and how it can simplify interpretation and reporting workflows, reducing sample TAT.
